The effect of insulin degludec in combination with liraglutide and metformin in patients with type 2 diabetes requiring treatment intensification

被引：0
|
作者：
Aroda, V. R. [1 ]
Bailey, T. [2 ]
Cariou, B. [3 ]
Kumar, S. [4 ,5 ]
Leiter, L. A. [6 ]
Raskin, P. [7 ]
Zacho, J. [8 ]
Bandier, M. [8 ]
Philis-Tsimikas, A. [9 ]
机构：
[1] MedStar Hlth Res Inst, Hyattsville, MD USA
[2] AMCR Inst Inc, Escondido, CA USA
[3] Nantes Univ Hosp, Dept Endocrinol, Nantes, France
[4] Univ Hosp Coventry, WISDEM Ctr, Coventry, W Midlands, England
[5] Univ Hosp Warwickshire, WISDEM Ctr, Coventry, W Midlands, England
[6] Univ Toronto, St Michaels Hosp, Toronto, ON M5S 1A1, Canada
[7] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[8] Novo Nordisk AS, Soborg, Denmark
[9] Scripps Whittier Diabet Inst, San Diego, CA USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
145
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [1] THE EFFECT OF INSULIN DEGLUDEC IN COMBINATION WITH LIRAGLUTIDE AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES REQUIRING TREATMENT INTENSIFICATION
    Aroda, V.
    Bailey, T.
    Cariou, B.
    Kumar, S.
    Leiter, L.
    Raskin, P.
    Zacho, J.
    Bandier, M.
    Philis-Tsimikas, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S261 - S262
  • [2] Treatment intensification with insulin degludec improves glycaemic control in patients with Type 2 diabetes treated with liraglutide and metformin
    Kumar, S.
    Aroda, V.
    Bailey, T.
    Cariou, B.
    Leiter, L.
    Raskin, P.
    Zacho, J.
    Philis-Tsimikas, A.
    DIABETIC MEDICINE, 2015, 32 : 66 - 66
  • [3] Fixed Combination of Insulin Degludec and Liraglutide in Type 2 Diabetes Treatment
    Jaecke, E.
    Wilhelm, B.
    Kaiser, M.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (06): : 387 - 395
  • [4] Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetes
    Gough, Stephen C. L.
    Jain, Rajeev
    Woo, Vincent C.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (01) : 7 - 19
  • [5] FIRST FIXED-RATIO COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE FOR THE TREATMENT OF TYPE 2 DIABETES
    Rendell, M.
    DRUGS OF TODAY, 2015, 51 (03) : 185 - 196
  • [6] Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
    Minze, Molly G.
    Chastain, Lisa M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 471 - 478
  • [7] Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes
    Sarah L. Greig
    Lesley J. Scott
    Drugs, 2015, 75 : 1523 - 1534
  • [8] Efficacy and safety of a combination of insulin degludec and liraglutide (IDegLira) in patients with Type 2 diabetes after 1 year of treatment
    Gough, S. C. L.
    Woo, V. C.
    Rodbard, H. W.
    Linjawi, S.
    Poulsen, P.
    Korsholm, L.
    Bode, B. W.
    DIABETIC MEDICINE, 2015, 32 : 76 - 76
  • [9] Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes
    Greig, Sarah L.
    Scott, Lesley J.
    DRUGS, 2015, 75 (13) : 1523 - 1534
  • [10] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Oya, Junko
    Nakagami, Tomoko
    Hasegawa, Yukiko
    Kondo, Yuichiro
    Katamine, Aki
    Shimizu, Mika
    Kubota, Ryo
    Suda, Rika
    Babazono, Tetsuya
    DIABETOLOGY INTERNATIONAL, 2024, 15 (02) : 237 - 243
12345